ROBIN WHITSELL

Robin Whitsell is the founder and president of Whitsell Innovations (WI), Inc, a boutique regulatory writing and consulting firm. She has almost 30 years of life science industry experience and is recognized for her ability to provide consulting solutions to pharmaceutical, biotech, device, medical education, and medical communication clients.

Prior to founding WI, Ms. Whitsell was an assistant director of preclinical and clinical development at Inspire Pharmaceuticals. She worked as a clinical research scientist and team lead at GlaxoWellcome (now GlaxoSmithKline) in the neurology and psychiatry clinical development group. She began her career at Parexel International CRO.

Ms. Whitsell has degrees in biophysics and physics from Miami University in Oxford, Ohio, and interned at Los Alamos National Laboratory. Ms. Whitsell is a 2011 winner of the Count Me In M3 pitch competition and was selected for the business acceleration leadership training. She serves on the board for the DA4S, the Alliance for Science, is the track chair for the Medical Affairs and Scientific Communication Track of the Drug Information Association (DIA) Annual Global Meeting, serves on the Executive Forum of the American Medical Writers Association (AMWA), and teaches an annual graduate-level seminar in drug development for Howard University.